Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Promoter Methylation
100%
Human Gastric Carcinoma
100%
Epigenetic Inactivation
100%
RIZ1
100%
Methylation Status
28%
Gastric Carcinoma
28%
Mutation Status
21%
CpG Island Methylator Phenotype
21%
Quantitative PCR
14%
TP53 mutation
14%
Gastric Carcinoma Cell Line
14%
Chromatin
7%
Oncogenesis
7%
Microsatellite Instability-high (MSI-H)
7%
Gene Expression
7%
Non-associated
7%
Stomach
7%
MRNA Expression
7%
Single-strand Conformation Polymorphism
7%
Mucosa
7%
Common Mechanisms
7%
Human Breast Cancer
7%
In(III)
7%
Retinoblastoma Protein
7%
Non-neoplastic
7%
P53 Gene
7%
Gastric Tissue
7%
Methylation
7%
CpG Island
7%
Non-cancer
7%
Quantitative Methylation-specific PCR (Q-MSP)
7%
5-aza-2′-deoxycytidine
7%
Transcriptional Inactivation
7%
Hypermethylation
7%
Hypermethylated
7%
Demethylating Agents
7%
Frameshift mutation
7%
MKN28
7%
KATO-III
7%
Human Liver Cancer
7%
GenBank Accession number
7%
Zinc Finger Genes
7%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Methylation
66%
CpG Island
44%
P53
22%
Messenger RNA
22%
Transcription
22%
Carcinogenesis
11%
Gene Expression
11%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Reverse Transcription Polymerase Chain Reaction
11%
Retinoblastoma Protein
11%
Protein P53
11%
Single-Strand Conformation Polymorphism
11%
Decitabine
11%
Microsatellite
11%
Frameshift Mutation
11%
Demethylating Agent
11%
GenBank
11%
Chromatin
11%
Stomach
11%